利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

107 条记录 (耗时 0.025 秒)

    Display screen with animated graphical user interface
    2.
    外观设计
    Display screen with animated graphical user interface 有权

    公开(公告)号：USD1032623S1

    公开(公告)日：2024-06-25

    申请号：US29776041

    申请日：2021-03-26

    申请人： Beta Bionics, Inc.

    设计人： David Chi-Wai Lim ,  Edward R. Damiano ,  Michael J. Rosinko ,  Mads Henrik Dall

    摘要： This invention was made with U.S. Government support under Agreement No. W912CG20C0013, awarded by Defense Advanced Research Projects Agency. The Government has certain rights in the invention.
    FIG. 1 is a front view of a first image of a first embodiment of a display screen with animated graphical user interface embodying the new design;
    FIG. 2 is a front view of a second image thereof;
    FIG. 3 is a front view of a third image thereof;
    FIG. 4 is a front view of a fourth image thereof;
    FIG. 5 is a front view of a fifth image thereof;
    FIG. 6 is a front view of a sixth image thereof;
    FIG. 7 is a front view of a seventh image thereof;
    FIG. 8 is a front view of an eighth image thereof;
    FIG. 9 is a front view of a ninth image thereof;
    FIG. 10 is a front view of a tenth image thereof;
    FIG. 11 is a front view of an eleventh image thereof; and
    FIG. 12 is a front view of a twelfth image thereof.
    FIG. 12 is a front view of a first image of a second embodiment of a display screen with animated graphical user interface embodying the new design;
    FIG. 11 is a front view of a second image thereof;
    FIG. 10 is a front view of a third image thereof;
    FIG. 9 is a front view of a fourth image thereof;
    FIG. 8 is a front view of a fifth image thereof;
    FIG. 7 is a front view of a sixth image thereof;
    FIG. 6 is a front view of a seventh image thereof;
    FIG. 5 is a front view of an eighth image thereof;
    FIG. 4 is a front view of a ninth image thereof;
    FIG. 3 is a front view of a tenth image thereof;
    FIG. 2 is a front view of an eleventh image thereof; and,
    FIG. 1 is a front view of a twelfth image thereof.
    The broken line showing of a display screen with graphical user interface is included for the purpose of showing portions of the article which form no part of the claim.
    The appearance of the transitional image of a first embodiment of the claimed design sequentially transitions between the images shown in FIGS. 1-12. The appearance of the transitional image of a second embodiment of the claimed design sequentially transitions between the images shown in FIGS. 12-1. The process or period in which one image transitions to another image forms no part of the claimed design.

    Glucose control system with automated backup therapy protocol generation
    3.
    发明授权
    Glucose control system with automated backup therapy protocol generation 有权

    公开(公告)号：US11957876B2

    公开(公告)日：2024-04-16

    申请号：US17212984

    申请日：2021-03-25

    申请人： BETA BIONICS, INC.

    发明人： Edward B. Raskin ,  David Chi-Wai Lim ,  Michael J. Rosinko ,  Firas H. El-Khatib ,  Edward R. Damiano

    IPC分类号： A61M5/172

    CPC分类号： A61M5/1723 ,  A61M2205/52 ,  A61M2230/201

    摘要： An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.

    REMOTE MODIFICATION OF THERAPY DELIVERED BY AMBULATORY MEDICAMENT PUMP
    9.
    发明申请
    REMOTE MODIFICATION OF THERAPY DELIVERED BY AMBULATORY MEDICAMENT PUMP 有权

    公开(公告)号：US20220208331A1

    公开(公告)日：2022-06-30

    申请号：US17654913

    申请日：2022-03-15

    申请人： Beta Bionics, Inc.

    发明人： Michael J. Rosinko ,  Himanshu Patel ,  Edward R. Damiano ,  Firas H. El-Khatib

    IPC分类号： G16H20/17 ,  A61M5/142 ,  A61M5/172

    摘要： Ambulatory medical devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can transmit a request to modify blood glucose control therapy delivered to a subject. The request can be transmitted via a remote computing environment, the ambulatory medicament pump can include a medicament reservoir, a pump controller, a wireless data interface, and/or other elements. The device can receive an indication that the request to modify therapy is approved and, in response to the indication that the request to modify the blood glucose control therapy is approved, instruct the pump controller to modify the blood glucose control therapy delivered to the subject.

    MEDICAMENT PUMPS AND CONTROL SYSTEMS FOR MANAGING GLUCOSE CONTROL THERAPY DATA OF A SUBJECT
    10.
    发明申请
    MEDICAMENT PUMPS AND CONTROL SYSTEMS FOR MANAGING GLUCOSE CONTROL THERAPY DATA OF A SUBJECT 有权

    公开(公告)号：US20220189603A1

    公开(公告)日：2022-06-16

    申请号：US17653120

    申请日：2022-03-01

    申请人： Beta Bionics, Inc.

    发明人： Edward R. Damiano ,  Firas H. El-Khatib ,  Himanshu Patel ,  Michael J. Rosinko ,  Robert James LeBourdais

    IPC分类号： G16H20/17 ,  A61M5/172 ,  A61M5/142 ,  H04W4/80

    摘要： Glucose control systems are disclosed. An ambulatory medicament pump that is configured to wirelessly transmit one or more of a plurality of glucose control parameters and glucose control therapy data to a second ambulatory medicament pump is disclosed. A control system for transferring historical pump data from a first ambulatory medicament pump to a second ambulatory medicament pump is also disclosed. The control system can receive the historical pump data from a first ambulatory medicament pump, determine that at least one of a plurality of pairing conditions is satisfied to connect the data interface to the second ambulatory medicament pump, transmit, via the data interface, a pairing signal to the second ambulatory medicament pump, and transmit at least one of the therapy data associated with the delivery of the glucose control therapy or the glucose control parameter.